The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
In Vivo Pharmacodynamics of Antifungal Drugs in Treatment of Candidiasis
Open accessAbstract
The field of antimicrobial pharmacodynamics examines the relationship between drug pharmacokinetics and antimicrobial activity or host toxicity (9). These investigations have been valuable for defining optimal antimicrobial dosing regimens and validating in vitro susceptibility breakpoints (4, 14, 25). The concepts encompassing this discipline were defined initially with antibacterial compounds (9, 34, 35). With the advent of standardized and reproducible antifungal susceptibility testing, similar pharmacodynamic analyses have been undertaken (24). Both in vitro and in vivo models have been able to demonstrate a correlation between drug dose, the MIC for an organism, and outcome (15, 17, 18, 36, 37). These investigations have been important for describing the relative potencies of antifungal drugs against a number of important pathogens. More recent in vivo pharmacodynamic investigations have examined the relationship among drug dose, dosing interval, MIC, and treatment outcome to define the specific pharmacodynamic parameter and parameter magnitude predictive of antifungal drug activity. This minireview summarizes these in vivo antifungal pharmacodynamic investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model
Andes, D., Stamsted, T., & Conklin, R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.922-926.2001 · Cited by 180
Self-citationIn vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model
Andes, D., Marchillo, K., Stamstad, T., & Conklin, R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1193-1199.2003 · Cited by 98
Self-citationVan t Wout, J. W., Mattie, H., & van Furth, R. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.2.147 · Cited by 72
Cited by
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs
KIPP, J. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.019 · Cited by 529
Campoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients
Maschmeyer, G., Haas, A., & Cornely, O. A. (2007) · Drugs · doi:10.2165/00003495-200767110-00004 · Cited by 366
Metadata
- Authors
- Andes, D.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2003-04
- Volume
- 47
- Issue
- 4
- Pages
- 1179-1186
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2109311072
- Cited by
- 169
- References
- 5
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vivo Pharmacodynamics of Antifungal Drugs in Treatment of Candidiasis. https://app.cochat.ai/papers/10.1128/aac.47.4.1179-1186.2003
- The paper
- Andes, D. (2003). In Vivo Pharmacodynamics of Antifungal Drugs in Treatment of Candidiasis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.47.4.1179-1186.2003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.